Creative Planning’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $240M | Buy |
1,103,490
+59,677
| +6% | +$13.2M | 0.16% | 67 |
|
|
2025
Q4 | $239M | Buy |
1,043,813
+73,670
| +8% | +$16.8M | 0.17% | 64 |
|
|
2025
Q3 | $225M | Buy |
970,143
+131,060
| +16% | +$26.7M | 0.17% | 66 |
|
|
2025
Q2 | $156M | Sell |
839,083
-3,943
| -0.5% | -$733K | 0.13% | 73 |
|
|
2025
Q1 | $177M | Buy |
843,026
+81,953
| +11% | +$15.9M | 0.17% | 67 |
|
|
2024
Q4 | $135M | Buy |
761,073
+10,262
| +1% | +$1.89M | 0.13% | 73 |
|
|
2024
Q3 | $147M | Buy |
750,811
+33,225
| +5% | +$6.2M | 0.15% | 69 |
|
|
2024
Q2 | $123M | Buy |
717,586
+2,787
| +0.4% | +$462K | 0.13% | 74 |
|
|
2024
Q1 | $130M | Buy |
714,799
+31,489
| +5% | +$5.43M | 0.14% | 70 |
|
|
2023
Q4 | $106M | Buy |
683,310
+17,978
| +3% | +$2.62M | 0.2% | 67 |
|
|
2023
Q3 | $99.2M | Buy |
665,332
+54,826
| +9% | +$8.05M | 0.13% | 75 |
|
|
2023
Q2 | $82.3M | Buy |
610,506
+1,254
| +0.2% | +$184K | 0.11% | 85 |
|
|
2023
Q1 | $97.1M | Buy |
609,252
+16,426
| +3% | +$2.51M | 0.14% | 76 |
|
|
2022
Q4 | $95.8M | Buy |
592,826
+134,121
| +29% | +$20.6M | 0.14% | 73 |
|
|
2022
Q3 | $61.6M | Buy |
458,705
+2,433
| +0.5% | +$349K | 0.11% | 87 |
|
|
2022
Q2 | $69.9M | Buy |
456,272
+24,906
| +6% | +$3.81M | 0.12% | 83 |
|
|
2022
Q1 | $69.9M | Buy |
431,366
+23,152
| +6% | +$3.36M | 0.11% | 81 |
|
|
2021
Q4 | $55.3M | Buy |
408,214
+10,382
| +3% | +$1.23M | 0.09% | 91 |
|
|
2021
Q3 | $42.9M | Buy |
397,832
+4,143
| +1% | +$473K | 0.08% | 103 |
|
|
2021
Q2 | $44.3M | Sell |
393,689
-54,720
| -12% | -$6.16M | 0.08% | 99 |
|
|
2021
Q1 | $48.5M | Buy |
448,409
+8,904
| +2% | +$952K | 0.1% | 87 |
|
|
2020
Q4 | $47.1M | Buy |
439,505
+18,327
| +4% | +$1.76M | 0.1% | 86 |
|
|
2020
Q3 | $36.9M | Buy |
421,178
+35,371
| +9% | +$3.33M | 0.1% | 86 |
|
|
2020
Q2 | $37.9M | Buy |
385,807
+30,050
| +8% | +$2.65M | 0.11% | 78 |
|
|
2020
Q1 | $27.1M | Sell |
355,757
-9,873
| -3% | -$841K | 0.1% | 87 |
|
|
2019
Q4 | $32.4M | Sell |
365,630
-7,742
| -2% | -$643K | 0.1% | 88 |
|
|
2019
Q3 | $28.3M | Sell |
373,372
-2,431
| -0.6% | -$167K | 0.09% | 93 |
|
|
2019
Q2 | $27.3M | Buy |
375,803
+39,427
| +12% | +$3.1M | 0.09% | 92 |
|
|
2019
Q1 | $27.1M | Buy |
336,376
+20,721
| +7% | +$1.7M | 0.1% | 85 |
|
|
2018
Q4 | $29.1M | Buy |
315,655
+13,932
| +5% | +$1.23M | 0.12% | 73 |
|
|
2018
Q3 | $28.5M | Buy |
301,723
+15,702
| +5% | +$1.49M | 0.11% | 79 |
|
|
2018
Q2 | $26.5M | Buy |
286,021
+18,377
| +7% | +$1.79M | 0.1% | 81 |
|
|
2018
Q1 | $25.3M | Buy |
267,644
+6,521
| +2% | +$716K | 0.1% | 80 |
|
|
2017
Q4 | $25.3M | Buy |
261,123
+21,549
| +9% | +$2.03M | 0.11% | 79 |
|
|
2017
Q3 | $21.3M | Buy |
239,574
+6,527
| +3% | +$497K | 0.1% | 90 |
|
|
2017
Q2 | $16.9M | Sell |
233,047
-9,300
| -4% | -$625K | 0.09% | 92 |
|
|
2017
Q1 | $15.8M | Sell |
242,347
-9,565
| -4% | -$601K | 0.09% | 93 |
|
|
2016
Q4 | $15.8M | Sell |
251,912
-4,391
| -2% | -$268K | 0.1% | 95 |
|
|
2016
Q3 | $16.2M | Buy |
256,303
+20,173
| +9% | +$1.31M | 0.1% | 92 |
|
|
2016
Q2 | $14.6M | Buy |
236,130
+47,103
| +25% | +$2.87M | 0.11% | 87 |
|
|
2016
Q1 | $10.8M | Sell |
189,027
-2,417
| -1% | -$135K | 0.08% | 95 |
|
|
2015
Q4 | $11.3M | Buy |
191,444
+16,011
| +9% | +$922K | 0.09% | 96 |
|
|
2015
Q3 | $9.55M | Buy |
175,433
+16,401
| +10% | +$1.07M | 0.08% | 99 |
|
|
2015
Q2 | $10.7M | Buy |
159,032
+35,032
| +28% | +$2.29M | 0.1% | 94 |
|
|
2015
Q1 | $7.26M | Buy |
124,000
+10,315
| +9% | +$623K | 0.07% | 118 |
|
|
2014
Q4 | $7.44M | Buy |
113,685
+9,425
| +9% | +$594K | 0.08% | 111 |
|
|
2014
Q3 | $6.02M | Sell |
104,260
-8,000
| -7% | -$444K | 0.07% | 120 |
|
|
2014
Q2 | $6.34M | Buy |
112,260
+3,658
| +3% | +$192K | 0.08% | 107 |
|
|
2014
Q1 | $5.58M | Buy |
108,602
+26,648
| +33% | +$1.35M | 0.08% | 101 |
|
|
2013
Q4 | $4.33M | Buy |
81,954
+5,196
| +7% | +$255K | 0.07% | 106 |
|
|
2013
Q3 | $3.43M | Buy |
76,758
+986
| +1% | +$43.7K | 0.07% | 100 |
|
|
2013
Q2 | $3.13M | Buy |
+75,772
| New | +$3.31M | 0.07% | 96 |
|
Other funds holding ABBV
VCM
VPM
Creative Planning's ABBV Position: Q1 2026 in Review
Creative Planning increased its AbbVie (ABBV) stake by 5.7% in Q1 2026, buying an estimated $13.2M and bringing the position to 1,103,490 shares worth $240M. The position accounts for 0.16% of the portfolio, ranked #67.
Creative Planning first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Creative Planning held 1,103,490 shares of AbbVie worth $240M as of Q1 2026.
- Creative Planning bought 59,677 AbbVie shares in Q1 2026, an estimated $13.2M.
- AbbVie made up 0.16% of Creative Planning's portfolio in Q1 2026, its #67 holding.
- Creative Planning first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.